Novo Nordisk stock climbs 1.52% as obesity drug Liraglutide shows promise in young kids

Novo Nordisk A/S shares climbed by 1.52% today to 888.60 DKK, following the release of promising new data on its obesity drug Liraglutide, which has ... Read More